Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCAR -- Ignore unavailable to you. Want to Upgrade?

To: LORD ERNIE who wrote (440)	9/24/1999 12:56:00 PM
From: LORD ERNIE	Respond to of 467

Bruce Byots Joins MedCare Technologies as Director, Investor Relations OAK BROOK, Ill., Sep 20, 1999 (BUSINESS WIRE) -- MedCare Technologies, Inc. (NASDAQ: MCAR) announced today that Bruce Byots has joined the company as Director, Investor Relations. Byots will be responsible for developing, implementing and managing MedCare's overall investor and media relations program. Byots joins the company from Stone Container Corporation (now Smurfit-Stone Container Corporation), where he most recently served as Director of Investor Relations. He joined Stone in 1984 and was responsible for a variety of finance and treasury functions. He has fifteen-plus years of investor and financial relations experience and holds a B.S. in Finance from De Paul University. "We are very pleased to have Bruce join our team," said Jeff Aronin, President and Chief Executive Officer. "We have come a long way since conceptualizing and developing our MedCare Program, which is now regarded as the leading non-drug, non-surgical treatment program for millions of urinary incontinence sufferers. "Therefore, we feel it is now the appropriate strategic point to add someone like Bruce to help us further develop our investor and media relations strategy." MedCare Technologies, Inc. is a healthcare technology service company that focuses on under-served high growth markets. Its core business, the MedCare Program, is the leading and most comprehensive conservative therapy for treating incontinence, a hidden health condition that, at approximately $26 billion, costs more than diabetes and bypass surgery combined. This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, changes in insurance reimbursement, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. Copyright (C) 1999 Business Wire. All rights reserved. Distributed via COMTEX. CONTACT: MedCare Technologies, Inc. Bruce Byots, Investor Relations Department, 1-800-611-2288 Website: www.medcareonline.com or MedCare Technologies, Inc. Bill Mann, Manager, 800/611-2288 WEB PAGE: businesswire.com